| Website | vivacta.com |
| Category | BioTech |
| Phone | +44 (0)1795 419400 |
| Employees |
| TOTAL | $6.5M |
| VENTURE FUNDING TOTAL | $6.5M |
| Venture Round, 11/10 HBM BioVentures IDInvest Partners Spark Ventures Viking Venture Management | £4M |
Vivacta Limited, a Sittingbourne, UK-based medical diagnostics company that develops an innovative platform for point of care testing.
Vivacta’s innovative piezofilm technology platform enables the advancement of new nearâ€patient diagnostic products. The company has successfully developed a test for thyroid stimulating hormone (TSH), and is working on a multiple analyte cardiovascular diagnostic test for use in the emergency room and acute care settings, where there is a need for rapid diagnosis of possible heart attack and related timeâ€critical medical conditions.
